Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial
- 2k Downloads
Physical activity is supposed to decrease mortality of colorectal cancer (CRC) and is suggested to reduce side-effects of the disease and its treatment. However, the knowledge about the influence of exercise interventions on patients suffering from CRC and metastasized CRC (mCRC) is still sparse. One frequently observed side effect in mCRC is chemotherapy-induced peripheral neuropathy (CIPN). This randomized controlled trial investigated the influence of a supervised exercise program on CIPN in mCRC.
Thirty patients (stage IV) undergoing outpatient palliative treatment including a median of 23.5 chemotherapy cycles of various regimens were randomly assigned to an intervention or control group (IG, n = 17; CG, n = 13). The IG participated in an eight-week supervised exercise program, including endurance, resistance and balance training (2×/week for 60 min) whereas the CG received written standard recommendations to obtain physical fitness. CIPN was assessed using the FACT/GOG-NTX questionnaire. Moreover, endurance capacity (6MWT), strength (h1RM) and balance (GGT-Reha) were evaluated before (t 0) and after (t 1) the intervention as well as after 4 weeks follow-up (t2).
Neuropathic symptoms remained stable in the IG over time, while CIPN significantly worsened in the CG from t 0 to t 1 and t 0 to t 2. In contrast to the CG, the IG significantly improved in strength and balance function. Changes in CIPN correlated with changes in balance.
This is the first investigation showing positive effects of a multimodal exercise program on CIPN, balance and strength on mCRC patients in a palliative setting, thereby consequently increasing patients` quality of life. The results support earlier findings stating a positive influence of balance exercise on CIPN.
KeywordsExercise CIPN Balance Advanced colorectal cancer
We would like to thank all patients who participated in this clinical trial and all physicians and hospitals who supported recruitment, especially C. Müller, dpt. for internal oncology and hematology, Essen-Mitte Clinics.
The intervention was supported by Novitas BKK and AOK Rheinland/Hamburg.
Compliance with ethical standards
Conflict of interest
- 2.Knopf K, Iqbal SU, Thompson SF, Malangone E, Gorritz-Kindu M, Stern L, Sherman SA, Naoshy S, Wooten M, Andria ML (2013) Survival outcomes in U.S. patients with metastatic colorectal cancer: a retrospective database analysis. J Clin Oncol 31(suppl 4; abstr 559)Google Scholar
- 3.Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV (2013) Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol 31(21):2699–2707CrossRefPubMedGoogle Scholar
- 14.Basen-Engquist K, Parker PA, Eng C, Li Y, Johnson DB, Kee BK, Thomas SS, Wong L, Crocenzi TS, Song J, Fisch M (2015) Randomized trial of a home-based exercise intervention for patients with advanced colorectal cancer: effects on physical functioning and activity levels. J Clin Oncol 33(suppl; abstract 9633)Google Scholar
- 15.Cheville AL, Kollasch J, Vandenberg J, Shen T, Grothey A, Gamble G, Basford JR (2013) A home-based exercise program to improve function, fatigue, and sleep quality in patients with stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manag 45(5):811–821CrossRefGoogle Scholar
- 19.Pachman DR, Qin R, Seisler DK, Smith EM, Beutler AS, Ta LE, Lafky JM, Wagner-Johnston ND, Ruddy KJ, Dakhil S, Staff NP, Grothey A, Loprinzi CL (2015) Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III trial N08CB (alliance). J Clin Oncol 33(30):3416–3422CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Herman HK, Monfort SM, Pan XJ, Chaudhari AMW, Lustberg MB (2017) Effects of chemotherapy-induced peripheral neuropathy on postural control in cancer survivors. J Clin Oncol 35(suppl 5S; abstr 128)Google Scholar
- 30.Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309(13):1359–1367CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Land SR, Kopec JA, Cecchini RS, Ganz PA, Wieand HS, Colangelo LH, Murphy K, Kuebler JP, Seay TE, Needles BM, Bearden JD 3rd, Colman LK, Lanier KS, Pajon ER Jr, Cella D, Smith RE, O'Connell MJ, Costantino JP, Wolmark N (2007) Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol 25(16):2205–2211CrossRefPubMedGoogle Scholar
- 33.LeSuer DA, McCormick JH, Mayhew J, Wasserstein RL, Arnold MD (1997) The accuracy of prediction equations for estimating 1-RM performance in the bench press, squat, and deadlift. J Strength Cond Res 11(4):211–213Google Scholar
- 34.Gießing J (2003) Trainingsplanung und -steuerung beim Muskelaufbautraining. Das Konzept vom individuellen hypothetischen Maximalgewicht (h1RM) als methodische Alternative. Leistungssport 33(4):26–31Google Scholar
- 35.Baumann FT (2008) Krafttraining mit Krebspatienten. In: Baumann FT, Schüle K (eds) Bewegungstherapie und Sport bei Krebs: Leitfaden für die Praxis. Deutscher Ärzte-Verlag, Cologne, pp 65–66Google Scholar